1. Home
  2. FENG vs OSRHW Comparison

FENG vs OSRHW Comparison

Compare FENG & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FENG
  • OSRHW
  • Stock Information
  • Founded
  • FENG 1998
  • OSRHW N/A
  • Country
  • FENG China
  • OSRHW United States
  • Employees
  • FENG N/A
  • OSRHW 21
  • Industry
  • FENG Broadcasting
  • OSRHW
  • Sector
  • FENG Industrials
  • OSRHW
  • Exchange
  • FENG Nasdaq
  • OSRHW Nasdaq
  • Market Cap
  • FENG N/A
  • OSRHW N/A
  • IPO Year
  • FENG 2011
  • OSRHW 2023
  • Fundamental
  • Price
  • FENG $2.25
  • OSRHW $0.04
  • Analyst Decision
  • FENG
  • OSRHW
  • Analyst Count
  • FENG 0
  • OSRHW 0
  • Target Price
  • FENG N/A
  • OSRHW N/A
  • AVG Volume (30 Days)
  • FENG 10.6K
  • OSRHW N/A
  • Earning Date
  • FENG 05-14-2025
  • OSRHW N/A
  • Dividend Yield
  • FENG N/A
  • OSRHW N/A
  • EPS Growth
  • FENG N/A
  • OSRHW N/A
  • EPS
  • FENG N/A
  • OSRHW N/A
  • Revenue
  • FENG $97,280,369.00
  • OSRHW N/A
  • Revenue This Year
  • FENG N/A
  • OSRHW N/A
  • Revenue Next Year
  • FENG N/A
  • OSRHW N/A
  • P/E Ratio
  • FENG N/A
  • OSRHW N/A
  • Revenue Growth
  • FENG 1.04
  • OSRHW N/A
  • 52 Week Low
  • FENG $1.28
  • OSRHW N/A
  • 52 Week High
  • FENG $4.15
  • OSRHW N/A
  • Technical
  • Relative Strength Index (RSI)
  • FENG 53.58
  • OSRHW N/A
  • Support Level
  • FENG $2.05
  • OSRHW N/A
  • Resistance Level
  • FENG $2.38
  • OSRHW N/A
  • Average True Range (ATR)
  • FENG 0.22
  • OSRHW 0.00
  • MACD
  • FENG 0.00
  • OSRHW 0.00
  • Stochastic Oscillator
  • FENG 52.08
  • OSRHW 0.00

About OSRHW OSR Holdings Inc. Warrant

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: